Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Botulinum toxin for the management of depression: An updated review of the evidence and meta-analysis
Jara Schulze, Insa Neumann, Michelle Magid, et al.
Journal of Psychiatric Research (2021) Vol. 135, pp. 332-340
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update
Marco Pirazzini, Cesare Montecucco, Ornella Rossetto
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1521-1539
Open Access | Times Cited: 52
The Esthetic Use of Botulinum Toxins in Cancer Patients: Providing a Foundation for Future Indications
Marco Papagni, Monica Renga, Selene Mogavero, et al.
Toxins (2025) Vol. 17, Iss. 1, pp. 31-31
Open Access | Times Cited: 1
Botulinum Toxin Injections for Psychiatric Disorders: A Systematic Review of the Clinical Trial Landscape
Ilya Demchenko, Alyssa Swiderski, Helen Liu, et al.
Toxins (2024) Vol. 16, Iss. 4, pp. 191-191
Open Access | Times Cited: 7
Treatment of Depression with Botulinum Toxin
M. Axel Wollmer, Michelle Magid, Tillmann H. C. Krüger, et al.
Toxins (2022) Vol. 14, Iss. 6, pp. 383-383
Open Access | Times Cited: 26
Botulinum Toxin Treatment for Depression: A New Paradigm for Psychiatry
Eric Finzi
Toxins (2023) Vol. 15, Iss. 5, pp. 336-336
Open Access | Times Cited: 14
Immunogenicity of botulinum toxin products: the emergence of resistance and ways to overcome it
Smirnov Vv, V.N. Turenko, David Bagaev, et al.
Plastic Surgery and Aesthetic Medicine (2025), Iss. 1, pp. 125-125
Closed Access
Variation in Subtypes of Obsessive-Compulsive Traits in Migraine Patients Undergoing Onabotulinum Toxin A Therapy
Giovanna Viticchi, Lorenzo Falsetti, Chiara Di Felice, et al.
Toxins (2025) Vol. 17, Iss. 4, pp. 199-199
Open Access
Botulinum Neurotoxin Therapy for Depression: Therapeutic Mechanisms and Future Perspective
Yang Li, Tong Liu, Weifeng Luo
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 23
Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis
Andreas A. Argyriou, Emmanouil V. Dermitzakis, George S. Vlachos, et al.
Acta Neurologica Scandinavica (2022) Vol. 145, Iss. 6, pp. 676-683
Closed Access | Times Cited: 15
Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety
M. Axel Wollmer, Tigran Makunts, Tillmann H. C. Krüger, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Impact of botulinum toxin for facial aesthetics on psychological well-being and quality of life: Evidence-based review
Ines Novo Pereira, Haidar Hassan
Journal of Plastic Reconstructive & Aesthetic Surgery (2022) Vol. 75, Iss. 12, pp. 4450-4463
Open Access | Times Cited: 13
Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial
M. Axel Wollmer, Insa Neumann, Stefanie Jung, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 2, pp. 159-169
Closed Access | Times Cited: 10
Neuronal effects of glabellar botulinum toxin injections using a valenced inhibition task in borderline personality disorder
Tillmann H. C. Krüger, Jara Schulze, Agnès Bechinie, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Mood symptoms in cervical dystonia: Relationship with motor symptoms and quality of life
Shameer Rafee, Mahmood Al-Hinai, Gillian Douglas, et al.
Clinical Parkinsonism & Related Disorders (2023) Vol. 8, pp. 100186-100186
Open Access | Times Cited: 4
Facing depression: evaluating the efficacy of the EmpkinS-EKSpression reappraisal training augmented with facial expressions – protocol of a randomized controlled trial
Marie Keinert, Lena Schindler‐Gmelch, Lydia Helene Rupp, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
How Does Botulinum Toxin Inhibit Itch?
Parisa Gazerani
Toxins (2022) Vol. 14, Iss. 10, pp. 701-701
Open Access | Times Cited: 7
Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation
Soo‐Bin Kim, Hyoung Moon Kim, Haeryun Ahn, et al.
Toxins (2021) Vol. 14, Iss. 1, pp. 17-17
Open Access | Times Cited: 9
Efficacy of Onabotulinum Toxin A on Obsessive–Compulsive Traits in a Population of Chronic Migraine Patients
Giovanna Viticchi, Lorenzo Falsetti, Sergio Salvemini, et al.
Brain Sciences (2022) Vol. 12, Iss. 11, pp. 1563-1563
Open Access | Times Cited: 5
Has the COVID‐19 pandemic changed attitudes and behaviors concerning cosmetic care and procedures among patients presenting to the dermatology outpatient clinic? A multicenter study with 1437 participants
Melek Aslan Kayıran, Asude Kara Polat, Gökçen Alyamaç, et al.
Journal of Cosmetic Dermatology (2021) Vol. 20, Iss. 10, pp. 3121-3127
Open Access | Times Cited: 6
Epidemiological aspects of poisoning Infectious-toxic bacteria of botulism on food poisoning in Iran; A review study
Halleh Mirbehresi, Mohadeseh Pirhadi, Samira Shokri, et al.
Egyptian Journal of Veterinary Science (2021) Vol. 53, Iss. 1, pp. 25-30
Open Access | Times Cited: 5
Neuronal Hypotheses and Data on the Mechanisms of Action of Botulinum Neurotoxin Injections in Psychiatric Disorders
Tillmann H. C. Krüger, M. Axel Wollmer
Toxicon (2024) Vol. 237, pp. 107433-107433
Open Access
Botulinum Toxin Therapy-Future Perspectives
Bahman Jabbari
Springer eBooks (2024), pp. 293-322
Closed Access
Correlation between blepharospasm and psychological diseases: the anxiety, depression and sleep disorder study
Huina Zhang, Qi Gao, Jiajun Xie, et al.
International Journal of Ophthalmology (2024) Vol. 17, Iss. 11, pp. 2007-2013
Open Access
Training and clinical benefits
Sami Stagnell
BDJ (2024) Vol. 237, Iss. 10, pp. 791-792
Closed Access
Exploring the effect of glabellar Botulinum toxin injections on symptoms of anxiety and depression: A pilot study from a cosmetic patient population
Michael S. Wolfe, Arisa Ortiz, Rona Z. Silkiss
Deleted Journal (2024), pp. 100058-100058
Open Access
Page 1 - Next Page

Scroll to top